Stefanie Zorbas‐Seifried

1.9k total citations · 2 hit papers
6 papers, 1.7k citations indexed

About

Stefanie Zorbas‐Seifried is a scholar working on Oncology, Materials Chemistry and Organic Chemistry. According to data from OpenAlex, Stefanie Zorbas‐Seifried has authored 6 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Materials Chemistry and 2 papers in Organic Chemistry. Recurrent topics in Stefanie Zorbas‐Seifried's work include Metal complexes synthesis and properties (6 papers), Lanthanide and Transition Metal Complexes (4 papers) and Ferrocene Chemistry and Applications (2 papers). Stefanie Zorbas‐Seifried is often cited by papers focused on Metal complexes synthesis and properties (6 papers), Lanthanide and Transition Metal Complexes (4 papers) and Ferrocene Chemistry and Applications (2 papers). Stefanie Zorbas‐Seifried collaborates with scholars based in Austria, Germany and Switzerland. Stefanie Zorbas‐Seifried's co-authors include Bernhard K. Keppler, Haralabos Zorbas, Michael A. Jakupec, Christian G. Hartinger, B. Kynast, Michael Groessl, Walter Berger, Alexander Egger, Paul J. Dyson and M. Galanski and has published in prestigious journals such as Biochemistry, Inorganic Chemistry and Molecular Pharmacology.

In The Last Decade

Stefanie Zorbas‐Seifried

6 papers receiving 1.7k citations

Hit Papers

From bench to bedside – preclinical and early clinical de... 2006 2026 2012 2019 2006 2008 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)
    2006 860 citations Christian G. Hartinger, Stefanie Zorbas‐Seifried et al. Journal of Inorganic Biochemistry profile →
  2. KP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients
    2008 732 citations Christian G. Hartinger, Michael A. Jakupec et al. Chemistry & Biodiversity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefanie Zorbas‐Seifried Austria 6 1.4k 1.2k 389 278 221 6 1.7k
Robert Trondl Austria 14 1.1k 0.8× 876 0.7× 334 0.9× 192 0.7× 296 1.3× 15 1.5k
C. Scolaro Switzerland 10 1.7k 1.2× 1.6k 1.4× 371 1.0× 299 1.1× 358 1.6× 10 2.1k
Michael Melchart United Kingdom 12 1.7k 1.2× 1.6k 1.4× 447 1.1× 323 1.2× 480 2.2× 14 2.2k
Rhona Aird United Kingdom 11 2.0k 1.4× 1.8k 1.5× 575 1.5× 303 1.1× 459 2.1× 17 2.6k
Benoı̂t Bertrand France 25 973 0.7× 1.4k 1.2× 371 1.0× 435 1.6× 178 0.8× 47 2.1k
Orsolya Dömötör Hungary 23 930 0.7× 635 0.5× 424 1.1× 282 1.0× 283 1.3× 56 1.3k
Lara Massai Italy 26 1.0k 0.7× 847 0.7× 625 1.6× 296 1.1× 156 0.7× 88 1.9k
Oldřich Vrána Czechia 27 2.0k 1.4× 1.5k 1.3× 1.1k 2.9× 321 1.2× 204 0.9× 54 2.5k
Olivier Zava Switzerland 28 1.2k 0.9× 1.4k 1.2× 317 0.8× 415 1.5× 468 2.1× 32 2.0k
Carmen Navarro‐Ranninger Spain 30 1.8k 1.3× 1.9k 1.6× 553 1.4× 399 1.4× 364 1.6× 74 2.5k

Countries citing papers authored by Stefanie Zorbas‐Seifried

Since Specialization
Citations

This map shows the geographic impact of Stefanie Zorbas‐Seifried's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefanie Zorbas‐Seifried with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefanie Zorbas‐Seifried more than expected).

Fields of papers citing papers by Stefanie Zorbas‐Seifried

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefanie Zorbas‐Seifried. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefanie Zorbas‐Seifried. The network helps show where Stefanie Zorbas‐Seifried may publish in the future.

Co-authorship network of co-authors of Stefanie Zorbas‐Seifried

This figure shows the co-authorship network connecting the top 25 collaborators of Stefanie Zorbas‐Seifried. A scholar is included among the top collaborators of Stefanie Zorbas‐Seifried based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefanie Zorbas‐Seifried. Stefanie Zorbas‐Seifried is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Hartinger, Christian G., Michael A. Jakupec, Stefanie Zorbas‐Seifried, et al.. (2008). ChemInform Abstract: KP1019, A New Redox‐Active Anticancer Agent — Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients. ChemInform. 40(3). 5 indexed citations
2.
Hartinger, Christian G., Michael A. Jakupec, Stefanie Zorbas‐Seifried, et al.. (2008). KP1019, A New Redox‐Active Anticancer Agent – Preclinical Development and Results of a Clinical Phase I Study in Tumor Patients. Chemistry & Biodiversity. 5(10). 2140–2155. 732 indexed citations breakdown →
3.
Zorbas‐Seifried, Stefanie, R.O. John, Vladimir B. Arion, et al.. (2007). The First Ruthenium-Based Paullones:  Syntheses, X-ray Diffraction Structures, and Spectroscopic and Antiproliferative Properties in Vitro. Inorganic Chemistry. 46(9). 3645–3656. 36 indexed citations
4.
Zorbas‐Seifried, Stefanie, Michael A. Jakupec, Nikolay V. Kukushkin, et al.. (2006). Reversion of Structure-Activity Relationships of Antitumor Platinum Complexes by Acetoxime but Not Hydroxylamine Ligands. Molecular Pharmacology. 71(1). 357–365. 50 indexed citations
5.
Zorbas‐Seifried, Stefanie, et al.. (2006). DNA Interactions of pH-Sensitive, Antitumor Bis(aminoalcohol)dichloroplatinum(II) Complexes,. Biochemistry. 45(49). 14817–14825. 20 indexed citations
6.
Hartinger, Christian G., Stefanie Zorbas‐Seifried, Michael A. Jakupec, et al.. (2006). From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A). Journal of Inorganic Biochemistry. 100(5-6). 891–904. 860 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Trondl Breakdown of academic impact, for papers by C. Scolaro Breakdown of academic impact, for papers by Michael Melchart Breakdown of academic impact, for papers by Rhona Aird Breakdown of academic impact, for papers by Benoı̂t Bertrand Breakdown of academic impact, for papers by Orsolya Dömötör Breakdown of academic impact, for papers by Lara Massai Breakdown of academic impact, for papers by Oldřich Vrána Breakdown of academic impact, for papers by Olivier Zava Breakdown of academic impact, for papers by Carmen Navarro‐Ranninger
Rankless by CCL
2026